Drug
Aspirin 300mg
Aspirin 300mg is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
completed375%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_2
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
NCT05546320
completed
PGE2/IL-22 Pathway in Various Forms of Eczema
NCT04133506
active_not_recruitingphase_3
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
NCT02804815
completedphase_2
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
NCT05515120
Clinical Trials (4)
Showing 4 of 4 trials
NCT05546320Phase 2
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
NCT04133506
PGE2/IL-22 Pathway in Various Forms of Eczema
NCT02804815Phase 3
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
NCT05515120Phase 2
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4